Neuropeptide Y in PTSD, MDD, and chronic stress: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neuroscience Research"
DOI: 10.1002/jnr.24589
Abstract: Previous studies have suggested that neuropeptide Y (NPY) levels may be altered in patients with major depressive disorder (MDD), post‐traumatic stress disorder (PTSD) and chronic stress. We investigated, through systematic review and meta‐analysis, whether the… read more here.
Keywords: npy levels; chronic stress; stress; ptsd mdd ... See more keywords
A latent class analysis of PTSD symptoms among inner city primary care patients.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of psychiatric research"
DOI: 10.1016/j.jpsychires.2017.11.015
Abstract: OBJECTIVES Examine evidence for different subclasses of posttraumatic stress disorder (PTSD) symptoms in a sample of trauma exposed, low-income, predominantly African American men and women. Assess the relationship between PTSD subclasses with major depressive disorder… read more here.
Keywords: depression; ptsd mdd; latent class; ptsd symptoms ... See more keywords
Trazodone augmentation could be a beneficial treatment for persistent insomnia in patients with comorbid PTSD and MDD that are good responders to escitalopram or sertraline: A one-group pretest-posttest study
Sign Up to like & getrecommendations! Published in 2025 at "European Psychiatry"
DOI: 10.1192/j.eurpsy.2025.903
Abstract: Introduction Antidepressants are a valuable treatment option for patients with PTSD and MDD. Sleep is an important dimension of both: PTSD and MDD. Insomnia is a common residual symptom in patients with PTSD and MDD… read more here.
Keywords: augmentation could; insomnia; ptsd mdd; good responders ... See more keywords